After a progression-free survival win last year raised hopes for the combo’s potential in hepatocellular carcinoma, an overall survival miss brings the study to a close. More: Merck, Eisai scrap ambitions for Keytruda-Lenvima pairing in liver cancer subtype after survival
read moreAkebia Therapeutics has scrapped plans for a trial that could have expanded the patient population for its new anemia drug Vafseo, the company said. More: Akebia scraps plan for Vafseo trial after discussions with FDA Source: fierce
read moreEmma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. More: Emma Walmsley upholds £40B sales target in her final GSK CEO report
read moreIn a bid to ensure that the widest swath of people with generalized myasthenia gravis (gMG) can benefit from its blockbuster medicine, argenx is heading to the FDA with positive data in a subset of patients long overlooked in the
read more
SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA More: Sonoma Biotherapeutics reports promising early data from phase 1 rheumatoid arthritis trial Source: News
read more
Faster scans and same-day results improve patient experience across community sites More: Lincolnshire CDCs boost diagnostics with cutting-edge CT and ultrasound systems Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals